Urogenital or anorectal transmucosal vaccine delivery system

Details Urogenital or anorectal transmucosal vaccine delivery system Urogenital or anorectal transmucosal vaccine delivery system

2006-11-14

2006-11-14

Smith, Lynette R. F. (Department: 1645)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C424S203100, C424S436000

Reexamination Certificate

active

07135191

ABSTRACT:
The invention is directed to a suppository based vaccine delivery system for immunizing against urogenital and anorectally transmitted infectious disease in humans and animals and a method for treating the same. More particularly, this invention is directed to a suppository based vaccine delivery system for the prophylaxis against or treatment of urogenital or anorectal transmitted infectious diseases, such as from viral or microbial pathogens. The suppository based delivery system comprises vaccine and/or vaccine adjuvant(s) comprised of whole or fractionated viral or other microbial pathogens, or their purified cellular constituents, whether native, mutated, synthetic, cloned or recombinantly expressed, that consists of nucleic acids, proteins, lipids or other antigenic determinants capable of producing humoral or cellular-mediated immunity in humans or animals; and a polyethylene glycol base; wherein the suppository is adapted to be inserted into a bodily orifice of a human or animal so as to allow the suppository to be in contact with tissue of the bodily orifice to facilitate transfer of vaccine or vaccine adjuvant(s) material therethrough.

REFERENCES:
patent: 3551554 (1970-12-01), Herschler
patent: 3711602 (1973-01-01), Herschler
patent: 3773929 (1973-11-01), Huber et al.
patent: 3880991 (1975-04-01), Yolles
patent: 4221705 (1980-09-01), Kondo
patent: 4360593 (1982-11-01), Konishi et al.
patent: 4404144 (1983-09-01), Liang
patent: 4434159 (1984-02-01), Sekine et al.
patent: 4439194 (1984-03-01), Harwood et al.
patent: 4462984 (1984-07-01), Mizuno et al.
patent: 4606919 (1986-08-01), Stojkovic et al.
patent: 4746508 (1988-05-01), Carey et al.
patent: 4756907 (1988-07-01), Beck et al.
patent: 4820698 (1989-04-01), Degenhardt et al.
patent: 4849227 (1989-07-01), Cho
patent: 4863900 (1989-09-01), Pollock et al.
patent: 4873090 (1989-10-01), Clancy
patent: 4894237 (1990-01-01), Bellani et al.
patent: 4939284 (1990-07-01), Degenhardt
patent: 5002771 (1991-03-01), Purkaystha et al.
patent: 5057520 (1991-10-01), Chu et al.
patent: 5057523 (1991-10-01), Chu et al.
patent: 5096940 (1992-03-01), Mor
patent: 5149537 (1992-09-01), Azria et al.
patent: 5189066 (1993-02-01), Kelm et al.
patent: 5270344 (1993-12-01), Herman
patent: 5336666 (1994-08-01), Neway et al.
patent: 5364879 (1994-11-01), Herman
patent: 5449520 (1995-09-01), Frigerio et al.
patent: 5466463 (1995-11-01), Ford
patent: 5514670 (1996-05-01), Friedman et al.
patent: 5639473 (1997-06-01), Grinstaff et al.
patent: 5679360 (1997-10-01), de Lacharriere et al.
patent: 5681552 (1997-10-01), Shevade et al.
patent: 5681811 (1997-10-01), Ekwuribe
patent: 5712257 (1998-01-01), Carter
patent: 5733540 (1998-03-01), Lee
patent: 5776921 (1998-07-01), Gates et al.
patent: 5783194 (1998-07-01), Brown et al.
patent: 5840318 (1998-11-01), Marshall et al.
patent: 5840771 (1998-11-01), Oldham et al.
patent: 5853767 (1998-12-01), Melman
patent: 5854224 (1998-12-01), Lockett et al.
patent: 5858371 (1999-01-01), Singh et al.
patent: 5858401 (1999-01-01), Bhalani et al.
patent: 5906922 (1999-05-01), Whittaker et al.
patent: 5908845 (1999-06-01), Segev
patent: 6046179 (2000-04-01), Murch et al.
patent: 6099853 (2000-08-01), Hertelendy et al.
patent: 6121313 (2000-09-01), Gao et al.
patent: 6121317 (2000-09-01), Wu et al.
patent: 6136336 (2000-10-01), Tanaka et al.
patent: 6159174 (2000-12-01), Oldham et al.
patent: 6174532 (2001-01-01), Campo et al.
patent: 6200590 (2001-03-01), Eley
patent: 6218147 (2001-04-01), Lingwood
patent: 6294192 (2001-09-01), Patel et al.
patent: 6306993 (2001-10-01), Rothbard et al.
patent: 6309663 (2001-10-01), Patel et al.
patent: 6348583 (2002-02-01), Segev
patent: 6383471 (2002-05-01), Chen et al.
patent: 6420425 (2002-07-01), Melman
patent: 6531139 (2003-03-01), Gao et al.
patent: 6572863 (2003-06-01), Rovinski et al.
patent: 6576224 (2003-06-01), Osbakken et al.
patent: 6576633 (2003-06-01), Young et al.
patent: 6585980 (2003-07-01), Chan et al.
patent: 6649660 (2003-11-01), Ninkov
patent: 6660484 (2003-12-01), Charych et al.
patent: 6669951 (2003-12-01), Rothbard et al.
patent: 6890950 (2005-05-01), Boothman et al.
patent: 2002/0012680 (2002-01-01), Patel et al.
patent: 2002/0034498 (2002-03-01), Smith et al.
patent: 2003/0044434 (2003-03-01), Gao et al.
patent: 2005/0020576 (2005-01-01), Zhang et al.
patent: 0486959 (1992-05-01), None
patent: 95/11701 (1995-05-01), None
patent: 96/07426 (1996-03-01), None
patent: 97/03655 (1997-02-01), None
patent: 98/44788 (1998-10-01), None
patent: 99/31250 (1999-06-01), None
patent: 9958726 (1999-11-01), None
Uehling, David T. et al, The Journal of Urology, vol. 157, pp. 2049-2052, Jun. 1997.
Uehling et al, Journal of Urology, vol. 157(6), pp. 2049-2052, Vaginal mucosal immunization for recurrent urinary tract infection:phase II clinical trial.
Sutjipto, S et al, J of Virology, vol. 64(5), May 1990, p. 2290-2297, Inactivated Simian Immunodeficiency Virus Vaccine failed to protect Rhesus Macaques from Intravenous or Genital Mucosal Infection by delayed disease in Intravenously exposed animals.
Lacombe, K et al, Vaccine, vol. 23, 2004, pp. 623-628, Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children.
D' Cruz, O.J. et al, Current Pharmaceutical Design, vol. 10, 2004, pp. 315-336, Clinical Development of Microbiocides for the Prevention of HIV infection.
Orkin, S.H et al, Dec. 7, 1995, Report and Recommendations of the Panel to assess the NIH investment in Research on gene therapy.
Ellis, Ronald W, Ph.D., New Technologies for making vaccines, chapter 29, pp. 568-575, in Vaccines, W.B. Saunders Company 1988.
Boslego, John W. et al, Chapter 17, Gonorrhea vaccines, p. 211-223, in Vaccines and Immunotherapy, Pergamon Press, 1991.
Solco Basle Ltd. Brochure: SolcoUrovac, A Vaccine for the Treatment and Prophylaxis of Chronic Urinary Infections.
Robert F. Service, Medical Research—New Vaccines May Ward Off Urinary Tract Infections,Science, vol. 276, p. 533, Apr. 25, 1997.
David T. Uehling, et al., Decreased Immunologic Responsiveness Following Intensified Vaginal Immunization Against Urinary Tract Infection,The Journal of Urology, vol. 143, pp. 143-145, Jan. 1990.
David T. Uehling, et al., Urinary Glycosaminoglycan Levels Following Induced Cystitis in Monkeys,The Journal of Urology, vol. 139, pp. 1103-1105, May 1988.
Walter J. Hopkins, et al., Local and Systemic Antibody Responses Accompany Spontaneous Resolution of Experimental Cystitis in Cynomolgus Monkeys,Infection and Immunity, vol. 55, No. 9., pp. 1951-1956, Sep. 1987.
David T. Uehling, et al., Vaginal Immunization Against Induced Cystitis In Monkeys,The Journal of Urology, vol. 137, pp. 327-329, Feb. 1987.
Walter J. Hopkins, et al., In Vitro And In Vivo Adherence of UropathogenicEscherichia coliStrains,The Journal of Urology, vol. 135, pp. 1319-1321, Jun. 1986.
David T. Uehling, M.D., Future Approaches to the Management of Urinary Tract Infections,Urologic Clinics of North America, vol. 13, No. 4, pp. 749-758, Nov. 1986.
David T. Uehling, et al., A Quantitative In Vivo Assay For Bacterial Adherence To The Urethra,The Journal of Urology, vol. 133, pp. 316-318, Feb. 1985.
J. Jensen, et al., Enhanced Immune Response In The Urinary Tract Of The Rat Following Vaginal Immunization,The Journal of Urology, vol. 132, pp. 164-166.
D.T. Uehling, et al., Immunization Against Urinary Tract Infections,Journal d'Urologie, vol. 91, No. 1, pp. 23-26, 1985.
H. Rüttgers, E. Grischke, Elevation of Secretary IgA Antibodies in the Urinary Tract Immunostimulation for the Pre-Operative Treatment and Post-Operative Prevention of Urinary Tract Infections,Urologia Internationalis, vol. 42, No. 6, pp. 1-3, 1987.
E.M. Grischek, et al., Treatment of Bacterial Infections of the Female Urinary Tract by Immunization of the Patients,Urologia Internationalis, vol. 42, No. 5, pp. 1-4, 1987.
H. Rüttgers, et. al., Urinary Tract Infections in Women—Current Unsatisfactory Situation and Prospects of a New Therapeutic Concept,Urologia Internationalis, vol. 42, No. 5, pp. 1-6, 1987.
D. Kruze, et al., Urin

Affiliated with

Also associated with

Rating

Urogenital or anorectal transmucosal vaccine delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Urogenital or anorectal transmucosal vaccine delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urogenital or anorectal transmucosal vaccine delivery system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3699901